514 filings
Page 9 of 26
8-K
zwz8ql lh
6 May 15
Arqule Reports First Quarter 2015 Financial Results
12:00am
8-K
vvi88n9zm06indyrhye
4 Mar 15
Results of Operations and Financial Condition
12:00am
8-K
4nxv3
12 Nov 14
Arqule Announces Collaboration with Nih for Clinical
12:00am
8-K
jdasb6f tfe
10 Nov 14
Arqule Announces Positive Top-line Results of Nih- Sponsored Phase 2 Trial of Tivantinib In Prostate Cancer
12:00am
8-K
vxt uztf7vd9g
10 Nov 14
Arqule Announces Third Quarter Fiscal 2014 Results
12:00am
S-8 POS
emijc0504 1wa
23 Sep 14
Registration of securities for employees (post-effective amendment)
12:00am
S-8
7u7 dpxe8hs6cs4vx
23 Sep 14
Registration of securities for employees
12:00am
S-8
edm9a36 h1
23 Sep 14
Registration of securities for employees
12:00am
8-K
fkic09k uu4kkkfa
5 Aug 14
Arqule Reports Second Quarter 2014 Financial Results
12:00am
8-K
avvq8akcvq
30 May 14
Arqule Announces Data Presentations with Tivantinib to Be Featured at Asco 2014
12:00am
8-K
2uwd7p to
16 May 14
Report of Matters Voted Upon by Stockholders
12:00am
8-K
hgx3tcdypvx41 3ap97m
7 May 14
Arqule Reports First Quarter 2014 Financial Results
12:00am